adding glp-1 to insulin a receptor agonist was not associated with a lower likelihood of discontinuing existing basal therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation glp-1_analogs [TUSOM | Pharmwiki]
Pay in 4 interest-free payments of $7.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
![adding glp-1 to insulin a receptor agonist was not associated with a lower likelihood of discontinuing existing basal therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
![adding glp-1 to insulin a receptor agonist was not associated with a lower likelihood of discontinuing existing basal therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation glp-1_analogs [TUSOM | Pharmwiki]](https://openmedscience.com/wp-content/uploads/2025/07/GLP-1-is-more-than-just-a-weight-loss-aid.jpg)
![adding glp-1 to insulin a receptor agonist was not associated with a lower likelihood of discontinuing existing basal therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation glp-1_analogs [TUSOM | Pharmwiki]](https://www.bodylogicmd.com/wp-content/uploads/2025/08/GLP-1-pen.jpg.webp)
![adding glp-1 to insulin a receptor agonist was not associated with a lower likelihood of discontinuing existing basal therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation glp-1_analogs [TUSOM | Pharmwiki]](https://diabetesonthenet.com/wp-content/uploads/GLP-1RA_shopped.png)























